Fetosense in India

Fetosense is a patented AI-based wireless portable foetal heart rate monitor which requires no consumables or special expertise to operate on the field.

Project start date : 15/06/2019

Beneficiary country : Bangladesh India Nepal

Healthcare themes targeted

  • Mother and child health

Fields of application

  • Telemedicine (remote diagnosis and consultations)
  • Patient monitoring and medical data

Stage of development

  • Routine project/operational

Financing method

  • Public (grant/subsidies, call for proposals/call for tender, etc.)
  • Private (private investors, crowdfunding, philanthropy, etc.)
  • Government agency (USAID, etc.)

Area where the project is utilised

  • National (in one country only)

Economic model(s)

  • Revenue generated by the beneficiaries/healthcare facilities
  • Donations

Target audience

  • Healthcare professionals and structures (hospitals, healthcare centres/clinics, health networks)
  • Pregnant women

Project objectives

  • Decreased mortality
  • Decreased morbidity
  • Improved treatment

Materials used

  • Cellular (mobile) phone
  • Smartphone
  • Tablet

Technologies used

  • Mobile telecommunications (without data connection)
  • Internet
  • Mobile app (Android, iOS, Windows Phone, HTML5, etc.)

About the sponsor

CareNX Innovations Private Limited

CareNX is a multi-award-winning healthcare startup incubated from IIT Bombay India since 2015. CareNX has a vision to become a strong technology partner for healthcare facilities to deliver pregnancy & women care more efficiently and effectively. The team consists of a highly skilled interdisciplinary team of computer scientists, biomedical & public health experts and management. The team is mentored by professors from KEM Mumbai, IIT Bombay, the National University of Singapore (NUS) and MIT. As of today, CareNX’s products are in use by 1000+ medical facilities, 400000+ pregnancies cared, 2500+ gynaecologists, 1300+ health workers, 12 states, 6 countries, 2000+ villages and generated a cumulative revenue of USD 2 million.

CareNX has developed

  1. AanandiMaa (since 2015) – a remote antenatal check-up and high-risk pregnancy management platform
  2. Fetosense (since 2019) – a patented AI based smartphone enabled portable foetal heart monitor
  3. BellyBeat (since 2021) – a Self-foetal monitoring device for pregnant mothers at home
  4. SindiColopo (since 2023) – a patented AI based smartphone enabled portable Cervical Cancer screening device.

These efforts have been recognised and supported by global forums like G20, World Health Summit (WHS), UN Women, Global Micronutrient Forum (GMF), Innovation Forum Cambridge UK etc., and by government bodies like the Indian Prime Minister’s Office, IUSSTF, FICCI, DST etc., and by universities like IC2 University of Texas Austin, Stanford Business School, IIM Ahmedabad, IIT Bombay, Singularity University, Miller Center of Santa Clara University etc. and many more industries like Google, Yahoo, Motorola, Infosys, etc.

Sector : Industrial (Startups, enterprises, etc.)

Country of origin : India

Contact : Sponsor website Project website

Offline use


Open source


Open data


Independent evaluation

Yes, evaluated independently


  • State Government of 5 Indian States

    Institutions (Communities, public authorities, NGOs, foundations, etc.)

  • Philips, BSV

    Industrial (Startups, enterprises, etc.)

  • IITB, KEM, MIT D-Lab

    Academic entities (Universities, research laboratories, etc)

  • Helios Germany, Cloudnine India, Tata India

    Healthcare (professionals and structures)

  • 25+ NGO partners

    Institutions (Communities, public authorities, NGOs, foundations, etc.)

  • Botnar Foundation, GCC, Welcome Trust, QCT, Comic Relief, USAID etc.

    Institutions (Communities, public authorities, NGOs, foundations, etc.)